The immune cell transcriptome is modulated by vitamin D3 supplementation in people with a first demyelinating event participating in a randomized placebo-controlled trial

Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 262(2024) vom: 13. Mai, Seite 110183
1. Verfasser: Yeh, Wei Zhen (VerfasserIn)
Weitere Verfasser: Gresle, Melissa, Lea, Rodney, Taylor, Bruce, Lucas, Robyn M, Ponsonby, Anne-Louise, Mason, Deborah, Andrew, Julie, Campbell, Hamish, Morahan, Julia, Sampangi, Sandeep, Campagna, Maria Pia, Stankovich, Jim, Van der Walt, Anneke, Jokubaitis, Vilija, Butzkueven, Helmut
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2024
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Randomized Controlled Trial Journal Article Clinically isolated syndrome First demyelinating event Gene expression Multiple sclerosis Vitamin D Cholecalciferol 1C6V77QF41